Benzphetamine Hydrochloride has 4 known drug interactions based on U.S. FDA drug labeling data. Of these, 2 are contraindicated combinations that should be avoided entirely. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Cns Stimulants, Monoamine Oxidase Inhibitors (Maois), Other Anticholinergic Agents. Patients taking Benzphetamine Hydrochloride should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 4
- Contraindicated
- 2
- Major
- 1
- Moderate
- 1
Contraindicated (2)
- Benzphetamine Hydrochloride + Cns Stimulants— Benzphetamine hydrochloride tablets should not be used concomitantly with other CNS stimulants.
- Benzphetamine Hydrochloride + Monoamine Oxidase Inhibitors (Maois)— Hypertensive crises have resulted when sympathomimetic amines used concomitantly or within 14 days following use of mono…
Major (1)
- Benzphetamine Hydrochloride + Other Anticholinergic Agents— Combined use with other anorectic agents has not been studied and may have potential for serious cardiac problems.
Moderate (1)
- Benzphetamine Hydrochloride + Urinary Alkalinizing Agents— Urinary alkalinizing agents increase blood levels and decrease excretion of amphetamines.